| Similar Articles |
|---|
 |
Managed Care
May 2003
William Silverman |
A Health Care Management Company's Experience With Palivizumab - 1 Year Later The appropriate application of criteria for the use of palivizumab can save health plans a significant amount of money.   |
Managed Care
September 2003
William Silverman |
Is Selective Use of Palivizumab Appropriate in Premature Infants? In reference to the article in the May 2003 issue of Managed Care entitled "A Health Care Management Company's Experience with Palivizumab," the assertions made by William Silverman, MD, in that article deserve comment. |
American Family Physician
January 15, 2004
Robert Steiner |
Treating Acute Bronchiolitis Associated with RSV Treatment for infants with bronchiolitis caused by respiratory syncytial virus (RSV) includes supplemental oxygen, nasal suctioning, fluids to prevent dehydration, and other supportive therapies. |
American Family Physician
February 15, 2003 |
Antiviral Drugs in the Immunocompetent Host: Part II. Treatment of Influenza and Respiratory Syncytial Virus Infections |
The Motley Fool
February 29, 2008
Brian Orelli |
RNAi Works -- Maybe Alnylam presents the first proof of concept that RNAi works in humans, but where's the proof that it cures a disease? |
The Motley Fool
June 9, 2009
Brian Orelli |
Alnylam Lays Down a Sacrifice Bunt RNAi is still an unproven technology, and there's plenty of chances for it to strike out. |
American Family Physician
June 15, 2005
Hall & Zalman |
Evaluation and Management of Apparent Life-Threatening Events in Children Many physicians have received a frantic call from an anxious parent stating that his or her child stopped breathing, became limp, or turned blue, but then quickly recovered. Approximately 50% of these children are diagnosed with an underlying condition that explains the apparent life-threatening event. |
American Family Physician
October 1, 2001
Michael Luszczak |
Evaluation and Management of Infants and Young Children with Fever Acute febrile illness in an infant or a young child is a common clinical scenario that can be a diagnostic challenge. The evaluation is guided by the history and physical examination, along with judiciously selected screening tests... |
American Family Physician
November 1, 2002
Hashim & Guillet |
Common Issues in the Care of Sick Neonates Some newborn infants require observation and care that is beyond the scope of a normal newborn nursery. In many hospitals, this level of care is designated intermediate, level II, or special care nursery. Infants in these nurseries may be managed by family physicians... |
The Motley Fool
August 31, 2010
Brian Orelli |
A Mostly Meaningless FDA Rejection The Food and Drug Administration sends AstraZeneca back to the drawing board for the second time when it rejected motavizumab, the drugmaker's newest treatment for respiratory syncytial virus. |
The Motley Fool
December 1, 2008
Brian Orelli |
It's Wait Until Next Year for These Drugmakers Drugs from AstraZeneca and Eli Lilly face delays because of the FDA. Both plan to resubmit their applications for approval in the first half of next year, but the delays likely will have different effects on the companies. |
The Motley Fool
November 14, 2008
Brian Orelli |
Gravy or Turkey From the FDA? Johnson & Johnson, Genzyme, and AstraZeneca should be made aware of their FDA fate over the next few weeks. |
